Prescription drug · ANDA
Diltiazem Hydrochloride NDC 62332-781
Diltiazem hydrochloride 30 mg/1 · Tablet, Film coated · Oral · Alembic Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62332-781-31 | 62332078131 | 100 TABLET, FILM COATED in 1 BOTTLE (62332-781-31)Marketed from Nov 14, 2025 | |
| 62332-781-71 | 62332078171 | 500 TABLET, FILM COATED in 1 BOTTLE (62332-781-71)Marketed from Nov 14, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Diltiazem Hydrochloride
- Generic name (nonproprietary)
- diltiazem hydrochloride
- Active ingredients
- Diltiazem hydrochloride — 30 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Alembic Pharmaceuticals Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 217633
- Marketing start
- Listing expires
- Other FDA classes
- Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)
- Identifiers
- Product ID 62332-781_2180c38c-9155-4c89-83c0-ea9e0bb568fbSPL ID 2180c38c-9155-4c89-83c0-ea9e0bb568fbSPL set ID ab38794a-914d-4bcd-9c6d-1578aa10041aRxCUI 831054, 831102, 831103, 833217UNII OLH94387TEUPC 0362332781317, 0362332782314
- Pharmacologic class
- Calcium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462332078131followed by a unit qualifier and the quantityPackage 62332-0781-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Diltiazem hydrochloride tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 217633
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Diltiazem Hydrochloride | Diltiazem hydrochloride 90 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-783 |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 60 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-782 |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 120 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-784 |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 60 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-782 |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 30 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-781 |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 90 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-783 |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 120 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-784 |